Oliver Surriga - Concepedia

Author

Oliver Surriga

Memorial Sloan Kettering Cancer Center

Also Known As

O Surriga, O. Surriga, Oliver Surriga

Publications

457

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Columbia University Irving Medical Center The Ohio State University Herbert Irving Comprehensive Cancer Center Sylvester Comprehensive Cancer Center

About

Oliver Surriga is an author at Memorial Sloan Kettering Cancer Center specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	149
2	Immunology	3	3	149
3	Cell Biology	2	2	130
4	Allergy	1	1	19
5	Hepatology	1	1	19

Oliver Surriga

Publications

447

Citations

H-Index

Page 1

	Year	Citations
Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs Parag P. Patwardhan, Oliver Surriga, Michael J. Beckman, Clinical Cancer Research	2014	118
Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model Oliver Surriga, Vinagolu K. Rajasekhar, Grazia Ambrosini, Molecular Cancer Therapeutics C-met InhibitorSkin CancerMedicinePhotocarcinogenesisMelanoma	2013	117
Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance Grazia Ambrosini, Christine A. Pratilas, Li-Xuan Qin, Clinical Cancer Research	2012	107
A Biparatopic Antibody–Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade John O. DaSilva, Katie Yang, Oliver Surriga, Molecular Cancer Therapeutics	2021	40
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy Shaheer Khan, Jose Lutzky, Alexander N. Shoushtari, Frontiers in Oncology	2022	22
Altered hepatic inflammatory response in the offspring following prenatal LPS exposure Oliver Surriga, Andres Ortega, Viren Jadeja, Immunology Letters InflammationPrenatal Lps ExposureAllergyHepatologyEarly Life Exposure	2009	19
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target Riyue Bao, Oliver Surriga, Daniel J. Olson, Melanoma Research Transcriptional RegulationTranscriptional AnalysisSkin CancerPhotocarcinogenesisMelanoma	2020	13
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy. Shaheer Khan, Jose Lutzky, Alexander N. Shoushtari, Journal of Clinical Oncology	2020	11

Page 1